📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Should the Benefit of Adjuvant Chemotherapy in Colon Cancer Be Re-Evaluated? (2016)

First Author: PÃ¥hlman LA
Attributed to:  Infrastructure for collaboration: Leeds MRC Medical Bioinformatics Centre funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1200/jco.2015.65.3048

PubMed Identifier: 26903571

Publication URI: http://europepmc.org/abstract/MED/26903571

Type: Journal Article/Review

Volume: 34

Parent Publication: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Issue: 12

ISSN: 0732-183X